Colistimethate (X-GEN Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Colistimethate drug offered from X-GEN Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: X-GEN Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: colistimethate sodium
SUBSTANCE NAME: COLISTIMETHATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-07-01
END MARKETING DATE: 0000-00-00


Colistimethate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionColistimethate from X-GEN Pharmaceuticals, Inc.
LABELER NAME: X-GEN Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/2mL)
START MARKETING DATE: 2016-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 39822-0617_790123d6-d683-4608-b838-1889de4b1835
PRODUCT NDC: 39822-0617
APPLICATION NUMBER: ANDA205356

Other COLISTIMETHATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
X-GEN Pharmaceuticals, Inc.Colistimethate
Xellia Pharmaceuticals ApSColistimethate